CDC committee backs Johnson & Johnson COVID-19 vaccine
The United States should resume use of the Johnson & Johnson COVID-19 vaccine for all adults, an independent advisory committee to the Centers for Disease Control and Prevention (CDC) said today. There is a small risk of a rare type of blood clot in women under 50, and health officials should warn patients of that risk, the committee stressed during its deliberations.
Federal officials at the CDC and Food and Drug Administration (FDA) could lift the pause on the shot based on that recommendation soon — within hours or days. The FDA will likely add a warning label to the vaccine about the blood clots.